Clinical Study | Office of Clinical Research

Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating The Use Of Adjuvant Endocrine Therapy +/- One Year Of Everolimus In Patients With H

Posted Date: May 15, 2019

Investigator: Mahmoud Charif
Specialties:
Type of Study: Drug

This study is to see whether treatment with everolimus plus hormone treatment after chemotherapy will increase the time without patients cancer returning. The current standard treatment after chemotherapy is hormone treatment alone. Everolimus is currently approved for the treatment of advanced or

Criteria:

Eligible Patients Must Have Hormone Responsive Breast Cancer That Has Already Been Removed By Surger

Keywords:

Brca, Breast Cancer, Her2, Metastatic Breast Ca, S1207

For More Information:

Uc Cancer Center
513-584-7698
cancer@uchealth.com

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List